Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
45
PCYO Quote, Financials, Valuation and Earnings
Last price:
$12.96
Seasonality move
:
21.1%
Day range:
$12.02 - $12.99
52-week range:
$8.94 - $14.63
Dividend yield:
0%
P/E ratio:
26.65x
P/S ratio:
10.85x
P/B ratio:
2.40x
Volume:
187.3K
Avg. volume:
54.2K
1-year change:
25.19%
Market cap:
$311M
Revenue:
$28.7M
EPS (TTM):
$0.25
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | $25.9M | $17.1M | $23M | $14.6M | $28.7M | |
| Revenue Growth (YoY) | 26.98% | -33.77% | 34.32% | -36.59% | 97.09% | |
| Cost of Revenues | $18.3M | $6.4M | $6.6M | $6.5M | $9M | |
| Gross Profit | $7.5M | $10.7M | $16.4M | $8M | $19.8M | |
| Gross Profit Margin | 29.18% | 62.62% | 71.18% | 55.12% | 68.73% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.3M | $5.1M | $5.9M | $5.5M | $6.9M | |
| Other Inc / (Exp) | $5.8M | $18.4M | $730K | $1.9M | $992K | |
| Operating Expenses | $4.6M | $5.5M | $6.3M | $6M | $7.5M | |
| Operating Income | $2.9M | $5.3M | $10.1M | $2.1M | $12.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.9M | $26.6M | $12.7M | $6.2M | $15.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $6.5M | $3.1M | $1.5M | $4M | |
| Net Income to Company | $6.8M | $20.1M | $9.6M | $4.7M | $11.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.8M | $20.1M | $9.6M | $4.7M | $11.6M | |
| Basic EPS (Cont. Ops) | $0.28 | $0.84 | $0.40 | $0.20 | $0.48 | |
| Diluted EPS (Cont. Ops) | $0.28 | $0.83 | $0.40 | $0.19 | $0.48 | |
| Weighted Average Basic Share | $23.8M | $23.9M | $24M | $24M | $24.1M | |
| Weighted Average Diluted Share | $24.1M | $24.1M | $24.2M | $24.1M | $24.1M | |
| EBITDA | $4.7M | $28.4M | $14.9M | $8.6M | $18.2M | |
| EBIT | $2.9M | $26.6M | $12.8M | $6.4M | $16.1M | |
| Revenue (Reported) | $25.9M | $17.1M | $23M | $14.6M | $28.7M | |
| Operating Income (Reported) | $2.9M | $5.3M | $10.1M | $2.1M | $12.2M | |
| Operating Income (Adjusted) | $2.9M | $26.6M | $12.8M | $6.4M | $16.1M | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | $10M | $4.9M | $10.9M | $3.4M | $12.6M | |
| Revenue Growth (YoY) | 5.83% | -51.61% | 124.24% | -69.04% | 272.92% | |
| Cost of Revenues | $6.2M | $1.5M | $2.3M | $1.6M | $2.8M | |
| Gross Profit | $3.9M | $3.4M | $8.5M | $1.8M | $9.8M | |
| Gross Profit Margin | 38.45% | 70.05% | 78.46% | 52.38% | 77.82% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.6M | $1.4M | $1.9M | $1.6M | $1.8M | |
| Other Inc / (Exp) | -$1.3M | $182K | $225K | $310K | $336K | |
| Operating Expenses | $1.7M | $1.5M | $2.1M | $1.7M | $2M | |
| Operating Income | $2.2M | $1.9M | $6.5M | $44K | $7.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $880K | $2.4M | $7.4M | $1.2M | $8.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $194K | $574K | $1.9M | $177K | $2.2M | |
| Net Income to Company | $686K | $1.8M | $5.6M | $1.1M | $6.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $686K | $1.8M | $5.6M | $1.1M | $6.6M | |
| Basic EPS (Cont. Ops) | $0.03 | $0.07 | $0.23 | $0.05 | $0.27 | |
| Diluted EPS (Cont. Ops) | $0.03 | $0.07 | $0.23 | $0.04 | $0.27 | |
| Weighted Average Basic Share | $23.9M | $23.9M | $24M | $24.1M | $24.1M | |
| Weighted Average Diluted Share | $24M | $24.1M | $24.1M | $24.1M | $24.1M | |
| EBITDA | $2.6M | $2.9M | $8.3M | $1.9M | $9.5M | |
| EBIT | $2.2M | $2.4M | $7.5M | $1.3M | $8.9M | |
| Revenue (Reported) | $10M | $4.9M | $10.9M | $3.4M | $12.6M | |
| Operating Income (Reported) | $2.2M | $1.9M | $6.5M | $44K | $7.8M | |
| Operating Income (Adjusted) | $2.2M | $2.4M | $7.5M | $1.3M | $8.9M | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | $25.9M | $17.1M | $23M | $14.6M | $28.7M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $18.3M | $6.4M | $6.6M | $6.5M | $9M | |
| Gross Profit | $7.5M | $10.7M | $16.4M | $8M | $19.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.3M | $5.1M | $5.9M | $5.5M | $6.9M | |
| Other Inc / (Exp) | $5.8M | $20M | $733K | $1.9M | $992K | |
| Operating Expenses | $4.6M | $5.5M | $6.3M | $6M | $7.5M | |
| Operating Income | $2.9M | $5.3M | $10.1M | $2.1M | $12.2M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $8.9M | $27.3M | $12.7M | $6.2M | $15.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $6.7M | $3.1M | $1.5M | $4M | |
| Net Income to Company | $6.8M | $20.1M | $9.6M | $4.7M | $11.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.8M | $20.7M | $9.6M | $4.7M | $11.6M | |
| Basic EPS (Cont. Ops) | $0.28 | $0.87 | $0.39 | $0.21 | $0.48 | |
| Diluted EPS (Cont. Ops) | $0.28 | $0.86 | $0.39 | $0.20 | $0.48 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | $4.7M | $29.1M | $14.9M | $8.6M | $18.2M | |
| EBIT | $2.9M | $27.3M | $12.8M | $6.4M | $16.1M | |
| Revenue (Reported) | $25.9M | $17.1M | $23M | $14.6M | $28.7M | |
| Operating Income (Reported) | $2.9M | $5.3M | $10.1M | $2.1M | $12.2M | |
| Operating Income (Adjusted) | $2.9M | $27.3M | $12.8M | $6.4M | $16.1M | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Revenue | $17.1M | $23M | $14.6M | $28.7M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $6.4M | $6.6M | $6.5M | $9M | -- | |
| Gross Profit | $10.7M | $16.4M | $8M | $19.8M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $5.1M | $5.9M | $5.5M | $6.9M | -- | |
| Other Inc / (Exp) | $20M | $733K | $1.9M | $992K | -- | |
| Operating Expenses | $5.5M | $6.3M | $6M | $7.5M | -- | |
| Operating Income | $5.3M | $10.1M | $2.1M | $12.2M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $27.3M | $12.7M | $6.2M | $15.6M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.7M | $3.1M | $1.5M | $4M | -- | |
| Net Income to Company | $20.1M | $9.6M | $4.7M | $11.6M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $20.7M | $9.6M | $4.7M | $11.6M | -- | |
| Basic EPS (Cont. Ops) | $0.87 | $0.39 | $0.21 | $0.48 | -- | |
| Diluted EPS (Cont. Ops) | $0.86 | $0.39 | $0.20 | $0.48 | -- | |
| Weighted Average Basic Share | $95.6M | $95.8M | $96.1M | $96.3M | -- | |
| Weighted Average Diluted Share | $96.4M | $96.6M | $96.5M | $96.6M | -- | |
| EBITDA | $29.1M | $14.9M | $8.6M | $18.2M | -- | |
| EBIT | $27.3M | $12.8M | $6.4M | $16.1M | -- | |
| Revenue (Reported) | $17.1M | $23M | $14.6M | $28.7M | -- | |
| Operating Income (Reported) | $5.3M | $10.1M | $2.1M | $12.2M | -- | |
| Operating Income (Adjusted) | $27.3M | $12.8M | $6.4M | $16.1M | -- | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $21.8M | $20.1M | $34.9M | $26M | $22.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.1M | $1.5M | $2.4M | $1.1M | $1.5M | |
| Inventory | $481K | -- | -- | $1.7M | $3.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1M | $1.1M | $467K | $346K | $530K | |
| Total Current Assets | $26M | $38.7M | $37.8M | $29.7M | $37.9M | |
| Property Plant And Equipment | $60.2M | $63.1M | $66.9M | $68.3M | $67.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $451K | $451K | $451K | $451K | |
| Other Long-Term Assets | $2M | $6.1M | $6.9M | $9.8M | $10.7M | |
| Total Assets | $89.8M | $117.2M | $129.2M | $133.2M | $147.4M | |
| Accounts Payable | $180K | $1.8M | $849K | $2M | $1.9M | |
| Accrued Expenses | $125K | $2.4M | $692K | $831K | $1.6M | |
| Current Portion Of Long-Term Debt | -- | -- | $10K | $31K | $64K | |
| Current Portion Of Capital Lease Obligations | $74K | $84K | $76K | $118K | $73K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $6.2M | $12.5M | $10.8M | $6.5M | $9.3M | |
| Long-Term Debt | -- | -- | $4M | $6.9M | $6.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.7M | $14.4M | $16.2M | $15M | $17.7M | |
| Common Stock | $80K | $80K | $80K | $80K | $80K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $82M | $102.7M | $113M | $118.2M | $129.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $82M | $102.7M | $113M | $118.2M | $129.7M | |
| Total Liabilities and Equity | $89.8M | $117.2M | $129.2M | $133.2M | $147.4M | |
| Cash and Short Terms | $21.8M | $20.1M | $34.9M | $26M | $22.1M | |
| Total Debt | -- | -- | $4M | $6.9M | $6.9M | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $21.8M | $20.1M | $34.9M | $26M | $22.1M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $1.1M | $1.5M | $2.4M | $1.1M | $1.5M | |
| Inventory | $481K | -- | -- | $1.7M | $3.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1M | $1.1M | $467K | $346K | $530K | |
| Total Current Assets | $26M | $38.7M | $37.8M | $29.7M | $37.9M | |
| Property Plant And Equipment | $60.2M | $63.1M | $66.9M | $68.3M | $67.5M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | $451K | $451K | $451K | $451K | |
| Other Long-Term Assets | $2M | $6.1M | $6.9M | $9.8M | $10.7M | |
| Total Assets | $89.8M | $117.2M | $129.2M | $133.2M | $147.4M | |
| Accounts Payable | $180K | $1.8M | $849K | $2M | $1.9M | |
| Accrued Expenses | $125K | $2.4M | $692K | $831K | $1.6M | |
| Current Portion Of Long-Term Debt | -- | -- | $10K | $31K | $64K | |
| Current Portion Of Capital Lease Obligations | $74K | $84K | $76K | $118K | $73K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $6.2M | $12.5M | $10.8M | $6.5M | $9.3M | |
| Long-Term Debt | -- | -- | $4M | $6.9M | $6.8M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $7.7M | $14.4M | $16.2M | $15M | $17.7M | |
| Common Stock | $80K | $80K | $80K | $80K | $80K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $82M | $102.7M | $113M | $118.2M | $129.7M | |
| Total Liabilities and Equity | $89.8M | $117.2M | $129.2M | $133.2M | $147.4M | |
| Cash and Short Terms | $21.8M | $20.1M | $34.9M | $26M | $22.1M | |
| Total Debt | -- | -- | $4M | $6.9M | $6.9M | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.8M | $20.1M | $9.6M | $4.7M | $11.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $517K | $497K | $603K | $539K | $436K | |
| Change in Accounts Receivable | -$24K | -$414K | $6.7M | -$3.3M | -$10.5M | |
| Change in Inventories | $6.5M | -- | -- | -- | -- | |
| Cash From Operations | $20.7M | $3.5M | $17.5M | -$2.3M | $2.2M | |
| Capital Expenditures | $8.6M | $2.9M | $5.8M | $7.8M | $2.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.4M | -$2.9M | -$6.7M | -$9.2M | -$4.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $4M | $3M | -- | |
| Long-Term Debt Repaid | -- | -- | -$40K | -$44K | -$31K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$581K | |
| Other Financing Activities | -$5K | -$2K | -$2K | -$111K | -- | |
| Cash From Financing | $45K | $87K | $4M | $2.8M | -$612K | |
| Beginning Cash (CF) | $4.5M | $21.8M | $22.4M | $37.2M | $28.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17.3M | $647K | $14.8M | -$8.7M | -$3.1M | |
| Ending Cash (CF) | $21.8M | $22.4M | $37.2M | $28.5M | $25.4M | |
| Levered Free Cash Flow | $12.1M | $560K | $11.6M | -$10.2M | -$461K | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $686K | $1.8M | $5.6M | $1.1M | $6.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $82K | $93K | $112K | -$20K | $56K | |
| Change in Accounts Receivable | -$438K | $430K | $16.8M | $940K | -$6.2M | |
| Change in Inventories | $3.9M | -- | -- | -- | -- | |
| Cash From Operations | $5.5M | $3.3M | $29.4M | $631K | $3M | |
| Capital Expenditures | $803K | $643K | $2M | $6.2M | $1M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$803K | -$643K | -$2.9M | -$3.4M | -$738K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | $3M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$40K | -$36K | -$8K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$142K | |
| Other Financing Activities | -$1K | $1K | -$1K | -- | -- | |
| Cash From Financing | $9K | $28K | $3M | $3M | -$150K | |
| Beginning Cash (CF) | $17.1M | $19.8M | $7.8M | $28.3M | $23.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.7M | $2.6M | $29.5M | $155K | $2.1M | |
| Ending Cash (CF) | $21.8M | $22.4M | $37.2M | $28.5M | $25.4M | |
| Levered Free Cash Flow | $4.7M | $2.6M | $27.4M | -$5.5M | $2M | |
| Period Ending | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.8M | $20.1M | $9.6M | $4.7M | $11.6M | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $517K | $497K | $603K | $539K | $436K | |
| Change in Accounts Receivable | -$24K | -$414K | $6.7M | -$3.3M | -$10.5M | |
| Change in Inventories | $6.5M | -- | -- | -- | -- | |
| Cash From Operations | $20.7M | $3.5M | $17.5M | -$2.3M | $2.2M | |
| Capital Expenditures | $8.6M | $2.9M | $5.8M | $7.8M | $2.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$3.4M | -$2.9M | -$6.7M | -$9.2M | -$4.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $4M | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -$40K | -$44K | -$31K | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$581K | |
| Other Financing Activities | -$5K | -$2K | -- | -$111K | -- | |
| Cash From Financing | $45K | $87K | $4M | $2.8M | -$612K | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $17.3M | $647K | $14.8M | -$8.7M | -$3.1M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $12.1M | $560K | $11.6M | -$10.2M | -$461K | |
| Period Ending | 2021-08-31 | 2022-08-31 | 2023-08-31 | 2024-08-31 | 2025-08-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $20.1M | $9.6M | $4.7M | $11.6M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | $497K | $603K | $539K | $436K | -- | |
| Change in Accounts Receivable | -$414K | $6.7M | -$3.3M | -$10.5M | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $3.5M | $17.5M | -$2.3M | $2.2M | -- | |
| Capital Expenditures | $2.9M | $5.8M | $7.8M | $2.7M | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$2.9M | -$6.7M | -$9.2M | -$4.7M | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $4M | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -$40K | -$44K | -$31K | -- | |
| Repurchase of Common Stock | -- | -- | -- | -$581K | -- | |
| Other Financing Activities | -$2K | -$2K | -$111K | -- | -- | |
| Cash From Financing | $87K | $4M | $2.8M | -$612K | -- | |
| Beginning Cash (CF) | $83.7M | $53M | $94.3M | $99.7M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $647K | $14.8M | -$8.7M | -$3.1M | -- | |
| Ending Cash (CF) | $84.3M | $67.8M | $85.5M | $96.6M | -- | |
| Levered Free Cash Flow | $560K | $11.6M | -$10.2M | -$461K | -- | |
Get PCYO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PCYO
Sector
P/E ratio
26.65x
14.18x
PEG ratio
0.19x
0.36x
P/B ratio
2.40x
1.35x
Price / LTM sales
10.85x
1.60x
Growth Metrics
PCYO
Sector
Revenue growth
10.54%
1.13%
Earnings growth
-14.29%
2.03%
Revenue (5-year growth)
7.14%
4.99%
Earnings forecast
--
$0.43
Profitability
PCYO
Sector
Profitability FY 2024
$19.8M
$1.5B
Return on invested capital
4.81%
3.64%
Return on assets
4.5%
2.58%
Return on equity
5.06%
8.33%
Earnings Date
Last Earnings Date
Nov
13
Next Earnings Date
Jan
16
Estimated Next Earnings Date
Feb
12
Balance Sheet
PCYO
Sector
Total cash
$20.5M
$441.3M
Short term investments
--
$145.7M
Total assets
$147.4M
$12.3B
Long term debt
$6.9M
$3.3B
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
